Bio-Rad Laboratories Inc (BIO) (Q3 2026) Earnings Call Highlights: Return to Currency-Neutral ...
Bio-Rad Laboratories Inc (BIO) posts 0.7% currency-neutral revenue growth, a 54.5% non-GAAP gross margin and $2.65 non-GAAP EPS, while flagging persistent academic funding and China headwinds. Related Stocks: BIO ,